Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 38.91
0.569 %
$ 2.15 B
Market Cap
36.36
P/E
SUPN - DEPRECIATION & AMORTIZATION
Depreciation & Amortization SUPN - Supernus Pharmaceuticals, Inc.
84.9 M
LAST VALUE
61.35%
2 YEAR CAGR
64.42%
5 YEAR CAGR
60.63%
10 YEAR CAGR